Y-Intercept (HK)’s Bionano Genomics BNGO Stock Holding History

Y-Intercept (HK)’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-757	Closed	-$277K	–	1090
2023 Q2	$277K	Buy	+757	New	+$342K	0.03%	801

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Y-Intercept (HK)'s BNGO Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 757 shares — an estimated $277K sold.

Y-Intercept (HK) first reported a position in BNGO in Q2 2023 and held it in 1 quarter. The position peaked at $277K in Q2 2023. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Y-Intercept (HK) reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 757 Bionano Genomics shares in Q3 2023, an estimated $277K.
Y-Intercept (HK) first reported a position in Bionano Genomics in Q2 2023 and held it in 1 quarter.
Y-Intercept (HK)'s Bionano Genomics position peaked at $277K in Q2 2023.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.